Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 62

1. A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib Journal of Comparative Effectiveness Research · 2024 · 7 citations
2. Effect of palbociclib plus letrozole on patient-reported health-related quality of life: extended follow-up of the PALOMA-2 trial ESMO Open · 2025 · 2 citations
3. Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq” Journal of cancer research updates · 2026
4. CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia EMBO Molecular Medicine · 2019 · 58 citations
5. Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis Journal of Advanced Research · 2024 · 8 citations
6. Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm Asia-Pacific Journal of Clinical Oncology · 2018 · 4 citations
7. Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events PLoS ONE · 2025 · 2 citations
8. Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China BMC Cancer · 2025 · 1 citations
9. Optimizing Scalp Cooling: (Ultra)Structural Follicular Characteristic and Restorative Advances Cancer Management and Research · 2025
10. Rare Case of Alopecia: Alopecia Neoplastica International Journal of Trichology · 2025

Community

— no results